Works by Hogan, W. J.

Results: 34

Long-term outcome of patients with multiple myeloma-related advanced renal failure following auto-SCT.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 7, p. 996, doi. 10.1038/bmt.2014.24

By:

Glavey, S V;
Gertz, M A;
Dispenzieri, A;
Kumar, S;
Buadi, F;
Lacy, M;
Hayman, S R;
Kapoor, P;
Dingli, D;
McCurdy, A;
Hogan, W J;
Gastineau, D A;
Leung, N

Publication type:

Article

Long-term outcome of patients with mutiple myeloma-related advanced renal failure following auto-SCT.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 12, p. 1543, doi. 10.1038/bmt.2013.109

By:

Glavey, S V;
Gertz, M A;
Dispenzieri, A;
Kumar, S;
Buadi, F;
Lacy, M;
Hayman, S R;
Dingli, D;
McCurdy, A;
Hogan, W J;
Gastineau, D A;
Leung, N

Publication type:

Article

Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 10, p. 1302, doi. 10.1038/bmt.2013.53

By:

Dispenzieri, A;
Seenithamby, K;
Lacy, M Q;
Kumar, S K;
Buadi, F K;
Hayman, S R;
Dingli, D;
Litzow, M R;
Gastineau, D A;
Inwards, D J;
Micallef, I N;
Ansell, S M;
Johnston, P B;
Porrata, L F;
Patnaik, M M;
Hogan, W J;
Gertz, M A A

Publication type:

Article

Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioning.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 5, p. 708, doi. 10.1038/bmt.2012.211

By:

DeCook, L J;
Thoma, M;
Huneke, T;
Johnson, N D;
Wiegand, R A;
Patnaik, M M;
Litzow, M R;
Hogan, W J;
Porrata, L F;
Holtan, S G

Publication type:

Article

Second auto-SCT for treatment of relapsed multiple myeloma.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 4, p. 568, doi. 10.1038/bmt.2012.183

By:

Gonsalves, W I;
Gertz, M A;
Lacy, M Q;
Dispenzieri, A;
Hayman, S R;
Buadi, F K;
Dingli, D;
Hogan, W J;
Kumar, S K

Publication type:

Article

Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 4, p. 557, doi. 10.1038/bmt.2012.170

By:

Gertz, M A;
Lacy, M Q;
Dispenzieri, A;
Kumar, S K;
Dingli, D;
Leung, N;
Hogan, W J;
Buadi, F K;
Hayman, S R

Publication type:

Article

Graft vs GIST?

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 9, p. 1246, doi. 10.1038/bmt.2011.247

By:

Holtan, S G;
Palmer, S R;
Okuno, S H;
Hogan, W J

Publication type:

Article

Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 7, p. 970, doi. 10.1038/bmt.2010.234

By:

Gertz, M. A.;
Lacy, M. Q.;
Dispenzieri, A.;
Kumar, S. K.;
Buadi, F. K.;
Dingli, D.;
Leung, N.;
Hogan, W. J.;
Hayman, S. R.

Publication type:

Article

SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalization.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 7, p. 956, doi. 10.1038/bmt.2010.233

By:

Gertz, M. A.;
Gastineau, D. A.;
Lacy, M. Q.;
Dispenzieri, A.;
Hayman, S. R.;
Kumar, S. K.;
Dingli, D.;
Leung, N.;
Wolf, R. C.;
Hogan, W. J.;
Buadi, F. K.

Publication type:

Article

The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 285, doi. 10.1038/bmt.2010.113

By:

Ehlers, S. L.;
Gastineau, D. A.;
Patten, C. A.;
Decker, P. A.;
Rausch, S. M.;
Cerhan, J. R.;
Hogan, W. J.;
Ebbert, J. O.;
Porrata, L. F.

Publication type:

Article

CD34<sup>+</sup> cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1699, doi. 10.1038/bmt.2010.49

By:

Holtan, S. G.;
Hogan, W. J.;
Elliott, M. A.;
Ansell, S. M.;
Inwards, D. J.;
Porrata, L. F.;
Johnston, P. B.;
Micallef, I. N.;
Lacy, M. Q.;
Gastineau, D. A.;
Litzow, M. R.

Publication type:

Article

Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia.

Published in:

Bone Marrow Transplantation, 2006, v. 37, n. 11, p. 1003, doi. 10.1038/sj.bmt.1705369

By:

Elliott, M. A.;
Tefferi, A.;
Hogan, W. J.;
Letendre, L.;
Gastineau, D. A.;
Ansell, S. M.;
Dispenzieri, A.;
Gertz, M. A.;
Hayman, S. R.;
Inwards, D. J.;
Lacy, M. Q.;
Micallef, I. N.;
Porrata, L. F.;
Litzow, M. R.

Publication type:

Article

Differential expression of interferon‐induced genes and other tissue‐based biomarkers in acute graft‐versus‐host disease vs. lupus erythematosus in skin.

Published in:

Clinical & Experimental Dermatology, 2019, v. 44, n. 4, p. e81, doi. 10.1111/ced.13759

By:

Lehman, J. S.;
Dasari, S.;
Damodaran, S. S.;
el‐Azhary, R. A.;
Gibson, L. E.;
Hashmi, S. K.;
Hogan, W. J.;
Kenderian, S. J.;
Patnaik, M. S.;
Litzow, M. R.;
Lazarus, H. M.;
Meves, A.

Publication type:

Article

Pharyngoesophageal motor function in patients with myotonic dystrophy.

Published in:

Annals of Neurology, 1981, v. 10, n. 5, p. 454, doi. 10.1002/ana.410100508

By:

Swick, H. M.;
Werlin, S. L.;
Dodds, W. J.;
Hogan, W. J.

Publication type:

Article

Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation.

Published in:

Bone Marrow Transplantation, 2001, v. 28, n. 3, p. 305, doi. 10.1038/sj.bmt.1703108

By:

Hogan, W J;
Lacy, M Q;
Wiseman, G A;
Fealey, R D;
Dispenzieri, A;
Gertz, M A

Publication type:

Article

Homomorphisms and congruences on ωα-bisimple semigroups.

Published in:

Journal of the Australian Mathematical Society, 1973, v. 15, n. 4, p. 441, doi. 10.1017/S1446788700028809

By:

Hogan, J. W.

Publication type:

Article

Amniotic fluid insulin at 14-20 weeks' gestation: association with later maternal glucose intolerance and birth macrosomia.

Published in:

2001

By:

Carpenter MW;
Canick JA;
Hogan JW;
Shellum C;
Somers M;
Star JA;
Carpenter, M W;
Canick, J A;
Hogan, J W;
Shellum, C;
Somers, M;
Star, J A

Publication type:

journal article

Experimental study of flame propagation in semiconfined geometries with obstacles

Published in:

Combustion Science & Technology, 1983, v. 30, n. 1-6, p. 105, doi. 10.1080/00102208308923614

By:

Urtiew, P. A.;
Brandeis, J.;
Hogan, W. J.

Publication type:

Article

Analysis of incomplete repeated measurements with dependent censoring times.

Published in:

Biometrika, 1998, v. 85, n. 1, p. 139, doi. 10.1093/biomet/85.1.139

By:

YAO, Q.;
WEI, L. J.;
HOGAN, J. W.

Publication type:

Article

AN UNPUBLISHED POEM OF PHILIP PENDLETON COOKE.

Published in:

Educational Forum, 1937, v. 1, n. 1, p. 81, doi. 10.1080/00131723609340015

By:

Hogan, W. J.

Publication type:

Article

Preparation, Separation and Identification of TMS Derivatives of Hydroxylated PCBS and Chlorophenols

Published in:

Bulletin of Environmental Contamination & Toxicology, 1978, v. 20, n. 1, p. 35

By:

Hogan, J. W.;
Stalling, D. L.

Publication type:

Article

Hexachlorobenzene (HCB) residues in fish

Published in:

Bulletin of Environmental Contamination & Toxicology, 1974, v. 11, n. 5, p. 393, doi. 10.1007/BF01685293

By:

Johnson, J. L.;
Hogan, J. W.;
Stalling, D. L.

Publication type:

Article

Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with "7+3".

Published in:

2022

By:

Begna, K. H.;
Xu, X.;
Gangat, N.;
Alkhateeb, H.;
Patnaik, M. M.;
Al-Kali, A.;
Elliott, M. A.;
Hogan, W. J.;
Litzow, M. R.;
Hook, C. C.;
Wolanskyj-Spinner, A. P.;
Mangaonkar, A.;
He, R.;
Pardanani, A.;
Shah, M.;
Ketterling, R. P.;
Tefferi, A.

Publication type:

Letter

European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00606-8

By:

Begna, K. H.;
Kittur, J.;
Gangat, N.;
Alkhateeb, H.;
Patnaik, M. S.;
Al-Kali, A.;
Elliott, M. A.;
Hogan, W. J.;
Litzow, M. R.;
Pardanani, A.;
Hanson, C. A.;
Ketterling, R. P.;
Tefferi, A.

Publication type:

Article

Prenatally diagnosed pseudoaneurysm of mitral-aortic intervalvular fibrous area.

Published in:

2022

By:

Hogan, W. J.;
Punn, R.;
Dean, P.;
Strainic, J.;
Rychik, J.;
Williams, R. V.;
Moon‐Grady, A. J.;
Silverman, N. H.;
Moon-Grady, A J

Publication type:

Case Study

Fetal cerebrovascular response to maternal hyperoxygenation in congenital heart disease: effect of cardiac physiology.

Published in:

2021

By:

Hogan, W. J.;
Moon‐Grady, A. J.;
Zhao, Y.;
Cresalia, N. M.;
Nawaytou, H.;
Quezada, E.;
Brook, M.;
McQuillen, P.;
Peyvandi, S.;
Moon-Grady, A J

Publication type:

journal article

Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 741, doi. 10.1038/leu.2014.306

By:

Pardanani, A;
Abdelrahman, R A;
Finke, C;
Lasho, T T;
Begna, K H;
Al-Kali, A;
Hogan, W J;
Litzow, M R;
Hanson, C A;
Ketterling, R P;
Tefferi, A

Publication type:

Article

Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinib.

Published in:

Leukemia (08876924), 2015, v. 29, n. 2, p. 498, doi. 10.1038/leu.2014.286

By:

Abdelrahman, R A;
Begna, K H;
Al-Kali, A;
Hogan, W J;
Litzow, M R;
Tefferi, A

Publication type:

Article

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis.

Published in:

Leukemia (08876924), 2013, v. 27, n. 6, p. 1322, doi. 10.1038/leu.2013.71

By:

Pardanani, A;
Laborde, R R;
Lasho, T L;
Finke, C;
Begna, K;
Al-Kali, A;
Hogan, W J;
Litzow, M R;
Leontovich, A;
Kowalski, M;
Tefferi, A

Publication type:

Article

Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies.

Published in:

Leukemia (08876924), 2012, v. 26, n. 5, p. 1119, doi. 10.1038/leu.2011.308

By:

Sinha, S;
Gertz, M A;
Lacy, M Q;
Dispenzieri, A;
Hayman, S R;
Buadi, F K;
Dingli, D;
Micallef, I N;
Hogan, W J;
Gastineau, D A;
Rajkumar, S V;
Kumar, S K

Publication type:

Article

A phase-2 trial of low-dose pomalidomide in myelofibrosis.

Published in:

Leukemia (08876924), 2011, v. 25, n. 2, p. 301, doi. 10.1038/leu.2010.254

By:

Begna, K. H.;
Mesa, R. A.;
Pardanani, A.;
Hogan, W. J.;
Litzow, M. R.;
McClure, R. F.;
Tefferi, A.

Publication type:

Article

JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival.

Published in:

Leukemia (08876924), 2010, v. 24, n. 1, p. 105, doi. 10.1038/leu.2009.225

By:

Tefferi, A.;
Lasho, T. L.;
Patnaik, M. M.;
Finke, C. M.;
Hussein, K.;
Hogan, W. J.;
Elliott, M. A.;
Litzow, M. R.;
Hanson, C. A.;
Pardanani, A.

Publication type:

Article

Sandifer syndrome: an unappreciated clinical entity.

Published in:

1980

By:

Werlin, Steven L.;
'Souza, Bernard J. D.;
Hogan, Walter J.;
Dodds, Wylie J.;
Arndorfer, Ronald C.;
Werlin, S L;
D'Souza, B J;
Hogan, W J;
Dodds, W J;
Arndorfer, R C

Publication type:

journal article

Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation.

Published in:

Transplant Infectious Disease, 2009, v. 11, n. 6, p. 519, doi. 10.1111/j.1399-3062.2009.00446.x

By:

Eid, A. J.;
Brown, R. A.;
Hogan, W. J.;
Lahr, B. D.;
Eckel-Passow, J. E.;
Litzow, M. R.;
Razonable, R. R.

Publication type:

Article